Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXKN6V
|
||||
| Drug Name |
SID90419368
|
||||
| Synonyms |
CHEMBL254412
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H14Cl2N6O
|
||||
| Canonical SMILES |
OCCCn1cnc2c(NCc3ccc(Cl)c(Cl)c3)nc(nc12)C#N
|
||||
| InChI |
InChI=1S/C16H14Cl2N6O/c17-11-3-2-10(6-12(11)18)8-20-15-14-16(23-13(7-19)22-15)24(9-21-14)4-1-5-25/h2-3,6,9,25H,1,4-5,8H2,(H,20,22,23)
|
||||
| InChIKey |
BDSGZPUKZJAYIB-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.